An Accountable Care Organization (ACO) is an entity that participates in Value-Based Care contracts with CMS (Medicare) and/or Medicare Advantage/Commercial health plans.
This simulation models Medicare Advantage and Commercial ACO dynamics where payers operate under market pressures. Medicare MSSP programs may differ—CMS actively adjusts rules to support ACO success.
- Start with "Realistic" — Use the Realistic preset for a grounded baseline
- Progress through each step — Each reveals a new layer of the financial reality
- Change one input at a time — See how each parameter affects the outcome
- Watch the money flow — Follow the savings from payer to physician and see where it goes
Set up the regional ACO parameters. Choose a preset scenario or customize individual values.
The math looks incredible on paper. Here's what the ACO could earn:
- Must save MORE than the Minimum Savings Rate (2%)
- Must achieve a Quality Score of at least 80%
If either requirement is missed, the payer keeps ALL savings — the ACO receives $0.
To achieve savings, the ACO needs infrastructure. An ACO cannot run with 100 fax machines.
If unfunded → ACO cannot operate → dissolution
If unsustainable → practice sells to hospital or PE
The figures above show annual costs. Since the ACO's first reconciliation check won't arrive for 18 months, the actual burden over this waiting period is calculated below.
The ACO "savings check" won't arrive for 18 months (performance year + 6 month claims lag). The ACO needs upfront capital.
The ACO needs $3.1M in infrastructure funding.
Each funding option involves different trade-offs between financial risk, operational control, and clinical autonomy.
| Bank Loan | Hospital | Payer Advance | Private Equity | |
|---|---|---|---|---|
| Personal Risk | High | Low | Medium | Low |
| PCP Control | Full | Shared | Shared | Limited |
| Upfront Cash | Yes | Yes | Monthly | Yes |
| Ongoing Cost | Loan payments | Referral premium | Clawback risk | Equity share |
- Performance Year 1: Months 0-12
- Claims runout period: Months 12-18 (6 months)
- Year 1 ACO share payment arrives: Month 18
Since no revenue arrives until Month 18, this loan defers all payments until then. Interest capitalizes during the deferral period, and repayments start at Month 19.
Hospitals require formation of a Physician-Hospital Organization (PHO) to structure the partnership. This allows shared savings arrangements and referral coordination that would otherwise face Stark Law restrictions on physician self-referrals.
The payer provides a monthly Per-Member-Per-Month (PMPM) payment during the 18-month operations period. If the ACO hits its targets, this advance is deducted from the ACO share before distribution. If targets are missed, the payer can claw back a percentage of the advance from future FFS revenue.
Note: Clawback is split evenly among participating PCPs.
- PE absorbs all financial risk
- In exchange: ACO board control as leverage over the practices
- PE incentives favor outcomes regardless of ACO success:
- ACO succeeds → they get gain-share
- ACO fails → they buy weakened practices at discount
After 18 months of ACO operations, it's time for reckoning...
These tabs represent "what-if" scenarios: TCOC Miss assumes the ACO achieved only 1% savings (below the MSR threshold), Quality Miss assumes quality targets were not met, and Hit Target shows successful performance.
- TCOC Miss: ACO achieved only 1% savings — below the MSR threshold, resulting in $0 payout
- Quality Miss: ACO quality score fell 10 points below the quality gate threshold
- Clawback Split: Any clawback owed is divided equally among all PCPs regardless of panel size
The Reality for Each PCP
Each PCP invested 18 months of effort worth $41K in lost revenue—and got nothing back. The loan remains: $3.5M owed, with $35K per PCP in personal guarantee liability.
- With $0 payout and loan payments due, where does the money come from?
- If PCPs signed personal guarantees, what assets are at risk?
- With financial distress visible to the market, what leverage do practices have when hospitals or PE come knocking?
The Reality for Each PCP
PCPs lost $41K each. 18 months of sacrificed revenue, gone. But the ACO is still locked into the referral agreement—and its weakened position is exactly what the hospital wanted.
Their "loss" pays for itself in 3-6 months of referral revenue. For a hospital system, the ACO's shared savings may matter less than securing referral volume and downstream revenue.
- Will the hospital continue funding the PHO after a miss? What will the hospital demand in return?
- If physicians want to exit, are independent FFS rates still where they were—or have payers ratcheted them down?
- What's stopping the hospital from requiring expanded referral lock-in or board control as the price of continued support?
The Reality for Each PCP
PE writes off their investment—it was a calculated risk. But they retain board control and operational relationships. PCPs absorbed $41K each in losses with nothing to show for it.
- PE absorbed the loss. What operational changes can PE mandate through board control—staffing, hours, practice consolidation?
- To continue funding, will PE demand additional board seats or governance rights?
- PE may push aggressive HCC/RAF coding to inflate future benchmarks. Who signs the attestations, and who faces regulatory liability?
The Reality for Each PCP
The PMPM advance felt like "free money" during operations—but the clawback wipes it out and more. Each PCP owes $135K to the payer (from future FFS revenue), plus absorbed $41K in practice burden.
- The payer fronted the advance knowing clawback was possible. What does this suggest about the payer's risk assessment of ACO success?
- With PCPs owing clawback from future FFS revenue, what leverage does the payer have in contract renewal negotiations?
- Would the payer offer the same PMPM rate next year—or is a reduced rate (or discontinuation) more likely?
The Uncomfortable Truth: Payers profit from quality failures—high gates, rejected supplemental data, narrow measures. They keep 100% of the ACO's savings.
The Reality for Each PCP
Each PCP invested 18 months of effort worth $41K in lost revenue—and got nothing back. The loan remains: $3.5M owed, with $35K per PCP in personal guarantee liability.
- With $0 payout and loan payments due, where does the money come from?
- The payer kept 100% of the savings the ACO generated. What incentive does the payer have to make quality gates achievable?
- If the ACO wants to renegotiate quality terms, what leverage does it have?
Double Loss: The ACO paid the hospital premium AND lost its share to the payer. Quality failure means payers keep 100% of realized savings.
The Reality for Each PCP
PCPs lost $41K each. 18 months of sacrificed revenue, gone. But the ACO is still locked into the referral agreement—and its weakened position is exactly what the hospital wanted.
Their "loss" pays for itself in 3-6 months of referral revenue. For a hospital system, the ACO's shared savings may matter less than securing referral volume and downstream revenue.
- Will the hospital continue funding the PHO after a miss? What will the hospital demand in return?
- If hospital referral patterns or EMR systems contributed to quality failures, who is accountable?
- The payer captured 100% of the savings generated. What incentive does the payer have to accept supplemental quality data from the ACO?
The Uncomfortable Truth: PE absorbs the loss, but payers keep 100% of savings. Quality gates are profit centers for payers.
The Reality for Each PCP
PE writes off their investment—it was a calculated risk. But they retain board control and operational relationships. PCPs absorbed $41K each in losses with nothing to show for it.
- PE absorbed the loss. Will PE fund quality improvement infrastructure, or push those costs onto individual practices?
- What happens to physician clinical autonomy when PE's board majority needs specific quality scores?
- Does PE have leverage to renegotiate quality terms with payers that independent physicians lack?
The Uncomfortable Truth: Not only does the payer keep ALL savings, they ALSO claw back the advance.
The Reality for Each PCP
The ACO hit savings targets but failed quality. The payer keeps ALL savings AND claws back the advance. This is the worst possible outcome—PCPs lose the advance AND their burden investment.
- The ACO generated real savings but gets nothing due to a quality technicality. Is this fair compensation for risk?
- With clawback owed AND quality failure, what incentive do PCPs have to continue participating?
- How might payers use quality gates strategically during contract negotiations?
The Reality for Each PCP
Each PCP gained $104K after accounting for 18 months of lost clinic time and staff costs. But the ACO isn't debt-free yet—$2.2M in loan payments remain.
- After reserves and loan set-asides, does the net gain justify 18 months of lost FFS revenue and administrative burden?
- Physicians still carry outstanding loan debt. If Year 2 misses, what's the exposure?
- With benchmark ratcheting, is Year 2 easier or harder to hit?
- What assumptions would need to change for this model to be sustainable long-term?
The Reality for Each PCP
- After PE's gain share, how much value actually reaches physicians compared to PE's return on investment?
- When PE exits, who decides the timing and the buyer—and do physicians share in the exit valuation?
- PE now has proof the model works. What prevents PE from demanding increased board control, management fees, and higher gain share next year?
- What assumptions would need to change for this model to be sustainable long-term?
The Reality for Each PCP
- The PMPM advance deduction significantly reduced net-to-PCPs. Is the upfront cash flow worth the reduced payout?
- With PMPM ratcheting down, how will the ACO fund Year 2 operations if advance drops to near-zero?
- The payer took minimal risk (advance is deducted or clawed back). What incentive does the payer have to continue the program?
- If the payer discontinues PMPM in Year 2, what funding source replaces it?
| Scenario | Bank Loan | Hospital | Payer Advance | Private Equity |
|---|---|---|---|---|
| TCOC Miss | -$122K | -$86K | -$176K | -$86K |
| Quality Miss | -$122K | -$86K | -$176K | -$86K |
| Hit Target | +$104K | -$28K | -$2K | +$16K |
Values show per-PCP net gain/loss after 18-month practice burden
Project ACO outcomes across multiple years to see long-term financial trajectory.
This projection models compounding pressures that determine how long an ACO remains viable. Four variable groups below control these dynamics — click any to expand and fine-tune:
- • Contract & Benchmark — Each year the ACO hits its target, payers ratchet down next year's benchmark. This shrinks achievable savings until the ACO cannot meet the MSR threshold.
- • Risk Adjustment (HCC/RAF) — RAF ratio determines whether beating the benchmark is easier or harder. Small changes cascade through all financial outcomes.
- • Quality Dynamics — Payers ratchet up quality requirements annually while ACOs have a ceiling on achievable quality. When the gate exceeds this ceiling, quality failure becomes inevitable — even with perfect cost optimization.
- • Inflation & Growth — TCOC inflation affects the benchmark and cost trajectory over time.
How to read this table: Start with Year 1, then follow the Status column to see when benchmark ratcheting or quality gate escalation causes the ACO to miss its targets.
| Year | Benchmark (RAF-adjusted) |
Achievable Savings (% of benchmark) |
ACO Share (payer payout) |
ACO Ops Retention (infrastructure) |
ACO Reserve Change (contribution) |
ACO Total Reserve (cumulative) |
Loan Payment (annual) |
Net to PCPs (after deductions) |
Status |
|---|
5-Year Summary — adjust projection years in the Financial view.
Monte Carlo simulation stress-tests the ACO model by running thousands of iterations with varied parameters.
Triangular: Values cluster around the base scenario, with lower probability at extremes. More realistic for typical market conditions.
Run a simulation to see results
Configure the settings above and click "Run Simulation" to explore the distribution of possible outcomes.